Archives of Medical Research
Volume 41, Issue 4 , Pages 251-254 , May 2010

Elevated Prevalence of Hepatitis B in Mexican Hemodialysis Patients. A Multicentric Survey

  • Ramón Paniagua

      Affiliations

    • Unit of Medical Investigation in Kidney Diseases, Instituto Mexicano del Seguro Social, México, D.F., México
    • ,
  • Angelina Villasís-Keever

      Affiliations

    • Research and Development, Bristol-Myers Squibb, México, D.F., México
    • Corresponding Author InformationAddress reprint requests to: Angelina Villasis, MD, Area Head, Bristol Myers Squibb, Virology & Immunology, Av Revolucion No. 1267, Col. Tlacopac, Del. Alvaro Obregón, Distrito Federal, 01049, Mexico; Phone: (+52) (55) 5337-2834; FAX: (+52) (55) 5593-1956
    • ,
  • María del Carmen Prado-Uribe

      Affiliations

    • Unit of Medical Investigation in Kidney Diseases, Instituto Mexicano del Seguro Social, México, D.F., México
    • ,
  • María-de-Jesús Ventura-García

      Affiliations

    • Unit of Medical Investigation in Kidney Diseases, Instituto Mexicano del Seguro Social, México, D.F., México
    • ,
  • Guadalupe Alcántara-Ortega

      Affiliations

    • Unit of Medical Investigation in Kidney Diseases, Instituto Mexicano del Seguro Social, México, D.F., México
    • ,
  • Samuel R. Ponce de Leon

      Affiliations

    • Laboratory of Biologics and Reagents of México, México, D.F., México
    • ,
  • Nancy Cure-Bolt

      Affiliations

    • Research and Development, Bristol-Myers Squibb, México, D.F., México
    • ,
  • Sigfrido Rangel-Frausto

      Affiliations

    • Research and Development, Bristol-Myers Squibb, México, D.F., México

Received 12 January 2010 ,Accepted 23 April 2010.

References 

  1. World Health Organization Fact Sheet; www.who.int
  2. Centers for Disease Control Fact Sheet; www.cdc.gov
  3. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, et al. Prevalence of hepatitis B infection and carrier status among adults in Mexico. Salud Publica Mex. 2007;49(suppl 3):S404–S411
  4. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine. 2000;18(suppl 1):S17–S19
  5. Fay OH. Hepatitis B in Latin America: epidemiological patterns and eradication surgery. Vaccine. 1990;8(suppl1):86–92
  6. Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63:2222–2229
  7. Finelli L, Miller J, Tokars J, et al. National Surveillance of Dialysis-Associated Diseases in the United Stated, 2002. Semin Dialysis. 2005;18:52–61
  8. Carl M, Francis DP, Maynard JE. A common-source outbreak of hepatitis B in a hemodialysis unit. Dial Transplant. 1983;12:222–229
  9. Alter MJ, Althone J, Maynard JE. Hepatitis B virus transmission associated with a multiple dose vial in a hemodialysis unit. Ann Intern Med. 1983;99:330–333
  10. Zaidi-Jacobson M, Navarrete-Romero ME, Romero-Oliveros MC, et al. Hepatitis B at a hemodialysis unit: description of an outbreak and control measures. Salud Publica Mex. 1990;32:269–275
  11. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep. 1988;37:377–382
  12. Fabrizi F, Bunnapradist S, Martin P. HBV infection in patients with end-stage renal disease. Semin Liver Dis. 2004;24(suppl 2):69–77
  13. Frenk J, Gonzalez-Pier E, Gomez-Dantes O, et al. Comprehensive reform to improve health system performance in Mexico. Lancet. 2006;368:1524–1534
  14. Norma Oficial Mexicana NOM-171-SSA1-1998, Para La Practica de Hemodialisis.
  15. Paniagua R, Ramos A, Fabian R, et al. Chronic kidney disease and dialysis in Mexico. Perit Dial Int. 2007;27:405–409
  16. Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis. 1986;153:1149–1151
  17. Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, et al. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transpl. 2009;20:681–684
  18. Al Hijazat M, Ajlouni YM. Hepatitis B infection among patients receiving chronic hemodialysis at the Royal Medical Services in Jordan. Saudi J Kidney Dis Transpl. 2008;19:260–267
  19. Cao YL, Wang SX, Zhu ZM. Hepatitis B viral infection in maintenance hemodialysis patients: a three year follow-up. World J Gastroenterol. 2007;13:6037–6040
  20. Thanachartwet V, Phumratanaprapin W, Desakorn V, et al. Viral hepatitis infections among dialysis patients: Thailand registry report. Nephrology (Carlton). 2007;12:399–405
  21. Moreira RC, Deguti MM, Lemos MF, et al. HBV markers in haemodialysis Brazilian patients: a prospective 12-month follow-up. Mem Inst Oswaldo Cruz. 2010;105:107–108
  22. Alberú J, Lisker-Melman M, González M, et al. Prevalence of hepatitis B and C in patients registered on the cadaver kidney transplant waiting list in Mexico. Transplant Proc. 1996;28:3298–3300
  23. Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63:2222–2229
  24. Thomas F, Patrice M. Chronic hepatitis virus infections in patients on renal replacement therapy. Nephrol Dial Transplant. 2004;19:1049–1053
  25. Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2009;24:1598–1603
  26. López L, López P, Arago A, et al. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay. J Clin Virol. 2005;34(suppl 2):S69–S74

PII: S0188-4409(10)00102-5

doi: 10.1016/j.arcmed.2010.05.001

Archives of Medical Research
Volume 41, Issue 4 , Pages 251-254 , May 2010

Article Tools